Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Prostate active surveillance

Jeff Tosoian • 15 Feb 2020
GU Cancers 2020
Genitourinary Cancer Prostate Cancer

Jeff Tosoian, MD, MPH, Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, discusses the use of active surveillance for the management of men with grade group 1 (GG1) prostate cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Jeff Tosoian

2:44
Predicting outcomes in RCC using cell cycle progression score
Jeff Tosoian • 13 Feb 2020

Related Videos

10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
3:07
Serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals